---
title: "Reflow Medical completes enrolment in the DEEPER REVEAL clinical trial"
date: "2024-05-17T12:43:22.000Z"
publishedDate: "17 mai 2024"
summary: "Reflow Medical has announced completion of enrolment in the DEEPER REVEAL clinical trial to evaluate the Reflow Spur stent. The company notes in a press release that the Spur—designated a Breakthrough Device by the US Food and Drug Administration (FDA)—is a unique clinical solution intended to provide stent-like results while leaving no metal behind."
importance: ""
sourceUrl: "https://vascularnews.com/reflow-medical-completes-enrolment-in-the-deeper-reveal-clinical-trial/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-05-17-reflow-medical-completes-enrolment-in-the-deeper-reveal-clinical-trial"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2024/05/reflow_logo_heart_2-featured.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/reflow-medical-completes-enrolment-in-the-deeper-reveal-clinical-trial/"
---

![Reflow Medical completes enrolment in the DEEPER REVEAL clinical trial](https://vascularnews.com/wp-content/uploads/sites/7/2024/05/reflow_logo_heart_2-featured.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/reflow-medical-completes-enrolment-in-the-deeper-reveal-clinical-trial/*

## L’essentiel

Reflow Medical has announced completion of enrolment in the DEEPER REVEAL clinical trial to evaluate the Reflow Spur stent. The company notes in a press release that the Spur—designated a Breakthrough Device by the US Food and Drug Administration (FDA)—is a unique clinical solution intended to provide stent-like results while leaving no metal behind.

## Lien source

https://vascularnews.com/reflow-medical-completes-enrolment-in-the-deeper-reveal-clinical-trial/
